LEXICON GENETICS INC.- MEETING DATE: MAY 19, 2004

Company

LEXICON PHARMACEUTICALS, INC.

Filed

April 15, 2004

Period of Report

May 19, 2004

Accession Number

0000950129-04-002120

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →